UK - Celtic Pharma apponts Dr Richards to advisory board
Biotechnology and pharmaceuticals-focused investor Celtic Pharma Holdings has appointed Dr Andy Richards to its advisory board.
Richards is currently chairman of Altacor and Novacta Biosciences, as well as a non-executive director of Vectura Group, Summit Corp, Biowisdom, Babraham Bioscience Technology, Cancer Research Technology and Arecor. He has also advised the UK government's office of life sciences on biotechnology issues, and is a founder member of the Cambridge Angels.
More on People
CapMan Managing Partner Johan Pålsson to depart
PУЅlsson resigns from management effective immediately; to stay as buyout partner until February 2024
Capvis grapples with EUR 1bn fundraise amid team exodus
Five partners for the Swiss-based GP leave firm in last two years; sponsor started sixth buyout fundraise in early 2023
Golding adds insurance expertise with hire for institutional clients team
Tim Ickenroth joins as director with prior experience at BNP Paribas and UniCredit
Travers Smith bolsters funds practice with hire from Proskauer
Tosin Adeyeri joins with particular experience in secondary portfolio transactions
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds